EP. 5: Real-World Insight: Lenvatinib for RAI-Refractory DTCByAndrew G. Gianoukakis, MDSeptember 25th 2020
EP. 7: Higher Dose Cabozantinib Demonstrates Superior Efficacy Over Lower Dose in MTCBySara KarlovitchOctober 7th 2021The 140 mg dosage was associated with a higher rate of adverse events and dose reductions.
